RDVY is a top choice for dividend growth investors. With strong criteria & tech exposure, it excels in returns. Click here to ...

Hyster-Yale faces challenges with three declining quarters after prior growth. Read here for an analysis of HY stock and why ...

Gold price comes under renewed selling pressure despite a combination of supporting factors.

The French government announced a 10-year framework contract with Eutelsat worth as much as €1 billion to provide ...

But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank ...

Trade uncertainties and rising geopolitical tensions also benefit the JPY’s safe-haven status.

Digital resources help students maintain momentum, combat the summer slide, and return to the classroom in the fall ready to ...

If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somato ...

Highlights Identical Sales without fuel increased 3.2%* Operating Profit of $1,322 million; EPS of $1.29 Adjusted FIFO Operating Profit of $1,518 ...

Objective We aimed to estimate prevalence and identify determinants of hypertension in adults aged 15–49 years in Tanzania.